Publication | Closed Access

Phase II Trial: Undifferentiated Versus Differentiated Autologous Mesenchymal Stem Cells Transplantation in Egyptian Patients with HCV Induced Liver Cirrhosis

Regenerative MedicineTransplantationHepatologyPhase Ii TrialViral HepatitisLiver PhysiologyStem Cell TransplantationImmunologyHepatitisComplications Of CirrhosisLiver DiseaseLiver TransplantationMedicineEgyptian PatientsCirrhosis